China Pharma Holdings (CPHI) Asset Utilization Ratio (2011 - 2026)
China Pharma Holdings' (CPHI) quarterly Asset Utilization Ratio came in at 0.09 in Q2 2026, down 72.27% on a YoY basis from 0.31 in Q2 2025, and down 16.9% quarter-over-quarter from 0.1 in Q1 2026.
Analysis
China Pharma Holdings (CPHI) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has reported Asset Utilization Ratio for 16 consecutive years, with 0.09 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Utilization Ratio fell 72.27% year-over-year to 0.09; the trailing twelve-month figure through Jun 2026 stood at 0.09 (down 72.27% YoY), and the FY2025 full-year result was 0.18, down 37.47% from the prior year.
- Asset Utilization Ratio slipped to 0.09 in Q2 2026 per CPHI's latest filing, from 0.1 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.5 in Q3 2023 and bottomed at 0.09 in Q2 2026.
- Historically, Asset Utilization Ratio has averaged 0.36 across 5 years, with a median of 0.4 in 2022.
- The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio increased 18.36% in 2023, then tumbled 72.27% in 2026.
- Over 5 years, Asset Utilization Ratio stood at 0.48 in 2022, then decreased by 7.6% to 0.44 in 2023, then retreated by 27.5% to 0.32 in 2024, then slumped by 44.57% to 0.18 in 2025, then slumped by 50.8% to 0.09 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.09, 0.1, and 0.18 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 0.57 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 0.31 |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 0.36 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 0.77 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 0.45 |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 | 0.09 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.09 |
| Mar 31, 2026 | 0.10 |
| Dec 31, 2025 | 0.18 |
| Sep 30, 2025 | 0.27 |
| Jun 30, 2025 | 0.31 |
| Mar 31, 2025 | 0.30 |
| Dec 31, 2024 | 0.32 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | 0.41 |
| Mar 31, 2024 | 0.39 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.50 |
| Jun 30, 2023 | 0.48 |
| Mar 31, 2023 | 0.48 |
| Dec 31, 2022 | 0.48 |
| Sep 30, 2022 | 0.47 |
| Jun 30, 2022 | 0.42 |
| Mar 31, 2022 | 0.41 |
| Dec 31, 2021 | 0.47 |
| Sep 30, 2021 | 0.51 |